SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Genesys (CEGE)
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1298 85 0 CEGE
Emcee:  Bharat Kalra Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
898 Basically, JT gets the Asian rights to the cancer vaccine by paying for half ofdavid james-5/1/2000
897 Can you tell me a bit about CEGE's collaboration with Japan Tobacco? What&#Luce Wildebeest-5/1/2000
896 Yes, there is still a fight with respect to the U.S. Epogen revenue, but Aventdavid james-4/28/2000
895 david, Might be a while before CEGE gets U.S. TKTX revenue. They keep losing tuck-4/28/2000
894 Top two stories on the New York Times are gene therapy and prostate cancer. nydavid james-4/28/2000
893 Gene therapy etc. Ken, yes, there are lots of ways to play the stock with optidavid james-4/28/2000
892 David, FWIW there are many ways to play this stock. Message 13516166 RegardsKFE-4/28/2000
891 We are going to see a lot of discussion of prostate cancer in the next few weekdavid james-4/27/2000
890 I'm in CEGE this morning at 17. The cash/stock position in this company is John Liu-4/27/2000
889 CEGE retains 4.852 million shares of ABGX after the split. Today's ABGX eardavid james-4/26/2000
888 Mama Bear, Thanks for straightening me out there. Misunderstood that 144. Aptuck-4/25/2000
887 Hi Tuck, CEGE's stake in ABGX is 8% instead of 12% is news to me [my clueleBosco-4/25/2000
886 tuck, CEGE retained 12% of ABGX after the follow on offering. <i>"IMama Bear-4/25/2000
885 david & bosco, For some insight as to when folks inside know about earningtuck-4/25/2000
884 Nice release. They made it clear this was not a gain in cash from an addition odavid james-4/25/2000
883 Hi all - earning release biz.yahoo.com to me, a mixed bag. As we know, the saBosco-4/25/2000
882 Hi Dave, Charles & all - Charles, not weird at all :). To a degree, I agreeBosco-4/19/2000
881 Maybe I'm weird, but I don't usually look at earnings or P/E of biotechCharles Tutt-4/19/2000
880 Hi Bosco, Yes, absolutely. CEGE did not receive milestone payments from JT thdavid james-4/19/2000
879 Hi Dave - no offense, as I consider you my cyberfriend, but we ve discussed thiBosco-4/18/2000
878 I don't think I understand your point. CEGE has made (so far) a $190 mill pdavid james-4/18/2000
877 >>The company should have a P/E of around 5 following earnings If you comts362-4/18/2000
876 Hi Jack & all - 1st, hope everyone is hanging tough. But remember, great foBosco-4/18/2000
875 The value of each CEGE share. 1. $7.80 in cash ($250 million) 2. $12.50 worth david james-4/18/2000
874 About 7 trading days until earnings. My guesstimate is $5.50/share in earnings david james-4/13/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News